ShareValue scores for 0OO9.LSE: Valuation 50, Quality 45, Growth 50, Health 53.

0OO9.LSE
LSE

Fresenius SE & Co KGAA O.N.

£0.47(+0.40%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
50
Fair Value
Price vs Value
Quality
45
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
53
Moderate
Financial Stability
Momentum
30
Bearish
Price Trend

Company Details

About

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026